Do we assume that Tali's latest research would outline positive findings, because I doubt businesses would further improve their commercialisation of their product without having it backed up by latest upcoming research? This would remove any doubt for those speculating around Tali, especially those who had questions raised by the previous research.
Tali Health 2020, page-1197
Add TD1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.295M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 22171956 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 15628165 | 19 |
View Market Depth
| Last trade - 16.12pm 18/11/2024 (20 minute delay) ? |
| TD1 (ASX) Chart |
Day chart unavailable